Boehringer Ingelheim and Zealand Pharma Receive FDA Fast Track Designation for BI 456906 for NASH

Ingelheim, Germany and Copenhagen, Denmark, 2 June, 2021 – Boehringer Ingelheim and Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078) today announced that the US Food and Drug Administration (FDA) has granted Fast Track Designation to...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials